US 10526370
Pentapeptide associated with integrin receptor alpha vbeta3
granted A61KA61K49/0041A61K49/0056
Quick answer
US patent 10526370 (Pentapeptide associated with integrin receptor alpha vbeta3) held by CHINA PHARMACEUTICAL UNIVERSITY expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CHINA PHARMACEUTICAL UNIVERSITY
- Grant date
- Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K49/0041, A61K49/0056, A61P, A61P35/00